Taiwan Journal of Ophthalmology is the official, peer-reviewed journal of the Ophthalmological Society of Taiwan (TOS), founded in May 1960 and is committed to active participation in eye care and the promotion of scientific research in ophthalmology. Articles are published open access under a Creative Commons Attribution-NonCommercial-ShareAlike License with no submission or publication fees. The aims of TJO are to increase the visibility of scientifically interesting and relevant articles for authors, and to create an international communication forum for globally-minded ophthalmologists. The journal encompasses all major subspecialties in the field of ophthalmology, with a special focus on ocular diseases that are prevalent in Southeast Asia. Each issue has a major theme that is focused on topics from a variety of subspecialties. The journal welcomes original innovative research, including up-to-date clinical studies and basic science research in ophthalmology, as well as related disciplines that are of interest to ophthalmic professionals. High-quality papers of other types, such as reviews, editorials, brief communications, letters to the editor, and case reports are also accepted.
Special features of the journal:
- Review articles from world-renowned experts: major reviews on specific topics by leading international ophthalmic experts in every issue
- Region-specific updates: high-quality papers reporting advanced findings on eye diseases prevalent in Southeast Asia (i.e., myopia, angle-closure glaucoma, polypoidal choroidal vasculopathy, infectious scleritis, pterygium) in every issue
- Fast publication speed
- Open access with no publication fee
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
DOAJ, Emerging Sources Citation Index, PubMed Central, SCOPUS, Web of Science
Impact Factor® as reported in the 2022 Journal Citation
Reports® (Clarivate Analytics, 2023): 1.1
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE),
International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
Now can be seen on American Academy of Ophthalmology (AAO):
Scope of the journal
The Taiwan Journal of Ophthalmology covers technical and clinical studies related to health, ethical and social issues in the field of Ophthalmology, including up-to-date clinical studies and basic science research, with special focus on Ocular Diseases that are prevalent in Southeast Asia. Articles with clinical interest and implications will be given preference.
Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 450+ medical journals in its portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new discoveries and improve patient care.
Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-review management system. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its journals.
Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2019) of €3.4 billion ($4.7 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.
Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access
Ms. Cindy Chen
Taiwan Journal of Ophthalmology
Ophthalmological Society of Taiwan
11F, No. 32, Kung-Yuan Road
Tel: (+886) 2-23146694
Fax: (+886) 2-23146835
E-mail: [email protected] or [email protected]